Increased expression of Zinc finger protein 267 in non-alcoholic fatty liver disease

International Journal of Clinical and Experimental Pathology

Volumn 4, Issue 7, 2011, Pages 661-666

  Schnabl, Bernd ^a,b   Czech, Barbara ^a   Valletta, Daniela ^a,b   Weiss, Thomas S ^a   Kirovski, Georgi ^a   Hellerbrand, Claus ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Kruppel like factor; Non alcoholic fatty liver disease; Znf267

Indexed keywords

MESSENGER RNA; PALMITIC ACID; REACTIVE OXYGEN METABOLITE; REPRESSOR PROTEIN; ZNF267 PROTEIN, HUMAN;

ARTICLE; CELL CULTURE; FATTY LIVER; GENETICS; HUMAN; LIPID METABOLISM; LIVER; LIVER CELL; METABOLISM; UPREGULATION;

CELLS, CULTURED; FATTY LIVER; HEPATOCYTES; HUMANS; LIPID METABOLISM; LIVER; PALMITIC ACID; REACTIVE OXYGEN SPECIES; REPRESSOR PROTEINS; RNA, MESSENGER; UP-REGULATION;

EID: 84855527239     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. McConnell BB and Yang VW. Mammalian Kruppel-like factors in health and diseases. Physiol Rev 2010; 90: 1337-1381.
2. Collins T, Stone JR, and Williams AJ. All in the family: the BTB/POZ, KRAB, and SCAN domains. Mol Cell Biol 2001; 21: 3609-3615.
3. Zhou J, Tan T, Tian Y, Zheng B, Ou JH, Huang EJ, and Yen TS. Kruppel-like factor 15 activates hepatitis B virus gene expression and replication. Hepatology 2011; 54: 109-121.
4. Li JC, Yang XR, Sun HX, Xu Y, Zhou J, Qiu SJ, Ke AW, Cui YH, Wang ZJ, Wang WM, Liu KD, and Fan J. Up-regulation of Kruppel-like factor 8 promotes tumor invasion and indicates poor prognosis for hepatocellular carcinoma. Gastroenterology 2010; 139: 2146-2157.
5. Ratziu V, Lalazar A, Wong L, Dang Q, Collins C, Shaulian E, Jensen S, and Friedman SL. Zf9, a Kruppel-like transcription factor up-regulated in vivo during early hepatic fibrosis. Proc Natl Acad Sci U S A 1998; 95: 9500-9505.
6. Wang SP, Zhou HJ, Chen XP, Ren GY, Ruan XX, Zhang Y, Zhang RL, and Chen J. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines. J Exp Clin Cancer Res 2007; 26: 117-124.
7. Miele L, Beale G, Patman G, Nobili V, Leathart J, Grieco A, Abate M, Friedman SL, Narla G, Bugianesi E, Day CP, and Reeves HL. The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease. Gastroenterology 2008; 135: 282-291.
8. Starkel P, Sempoux C, Leclercq I, Herin M, Deby C, Desager JP, and Horsmans Y. Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate nonalcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats. J Hepatol 2003; 39: 538-546.
9. Abrink M, Aveskogh M, and Hellman L. Isolation of cDNA clones for 42 different Kruppelrelated zinc finger proteins expressed in the human monoblast cell line U-937. DNA Cell Biol 1995; 14: 125-136.
10. Schafer U, Schneider A, and Neugebauer E. Identification of a nitric oxide-regulated zinc finger containing transcription factor using motif-directed differential display. Biochim Biophys Acta 2000; 1494: 269-276.
11. Schnabl B, Hu K, Muhlbauer M, Hellerbrand C, Stefanovic B, Brenner DA, and Scholmerich J. Zinc finger protein 267 is up-regulated during the activation process of human hepatic stellate cells and functions as a negative transcriptional regulator of MMP-10. Biochem Biophys Res Commun 2005; 335: 87-96.
12. Schnabl B, Valletta D, Kirovski G, and Hellerbrand C. Zinc finger protein 267 is upregulated in hepatocellular carcinoma and promotes tumor cell proliferation and migration. Exp Mol Pathol 2011;91:695-701.
13. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, and Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005; 42: 44-52.
14. Cohen JC, Horton JD, and Hobbs HH. Human fatty liver disease: old questions and new insights. Science 2011; 332: 1519-1523.
15. Stickel F and Hellerbrand C. Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications. Gut 2010; 59: 1303-1307.
16. Serfaty L and Lemoine M. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis. Diabetes Metab 2008; 34: 634-637.
17. Paradis V and Bedossa P. Definition and natural history of metabolic steatosis: histology and cellular aspects. Diabetes Metab 2008; 34: 638-642.
18. Lewis JR and Mohanty SR. Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci 2010; 55: 560-578.
19. Jou J, Choi SS, and Diehl AM. Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis 2008; 28: 370-379.
20. Vanni E, Bugianesi E, Kotronen A, De MS, Yki-Jarvinen H, and Svegliati-Baroni G. From the metabolic syndrome to NAFLD or vice versa? Dig Liver Dis 2010;42:320-330.
21. Tiniakos DG, Vos MB, and Brunt EM. Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol 2010; 5: 145-171.
22. Wobser H, Dorn C, Weiss TS, Amann T, Bollheimer C, Buttner R, Scholmerich J, and Hellerbrand C. Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells. Cell Res 2009; 19: 996-1005.
23. Weiss TS, Jahn B, Cetto M, Jauch KW, and Thasler WE. Collagen sandwich culture affects intracellular polyamine levels of human hepatocytes. Cell Prolif 2002; 35: 257-267.
24. Hellerbrand C, Amann T, Schlegel J, Wild P, Bataille F, Spruss T, Hartmann A, and Bosserhoff AK. The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma. Gut 2008; 57: 243-251.
25. Wobser H, Dorn C, Weiss TS, Amann T, Bollheimer C, Buttner R, Scholmerich J, and Hellerbrand C. Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells. Cell Res 2009; 19: 996-1005.
26. Dorn C, Riener MO, Kirovski G, Saugspier M, Steib K, Weiss TS, Gabele E, Kristiansen G, Hartmann A, and Hellerbrand C. Expression of fatty acid synthase in nonalcoholic fatty liver disease. Int J Clin Exp Pathol 2010; 3: 505-514.
27. Muhlbauer M, Bosserhoff AK, Hartmann A, Thasler WE, Weiss TS, Herfarth H, Lock G, Scholmerich J, and Hellerbrand C. A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV -related liver disease. Gastroenterology 2003; 125: 1085-1093.
28. Hellerbrand C, Bataille F, Schlegel J, Hartmann A, Muhlbauer M, Scholmerich J, Buttner R, Hofstadter F, and Bosserhoff AK. In situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased livers. Liver Int 2005; 25: 357-366.
29. Collins JM, Neville MJ, Hoppa MB, and Frayn KN. De novo lipogenesis and stearoyl-CoA desaturase are coordinately regulated in the human adipocyte and protect against palmitate-induced cell injury. J Biol Chem 2010; 285: 6044-6052.
30. Hellerstein MK, Schwarz JM, and Neese RA. Regulation of hepatic de novo lipogenesis in humans. Annu Rev Nutr 1996; 16: 523-557.
31. Nakamura S, Takamura T, Matsuzawa-Nagata N, Takayama H, Misu H, Noda H, Nabemoto S, Kurita S, Ota T, Ando H, Miyamoto K, and Kaneko S. Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria. J Biol Chem 2009; 284: 14809-14818.
32. Liu JF, Ma Y, Wang Y, Du ZY, Shen JK, and Peng HL. Reduction of lipid accumulation in HepG2 cells by luteolin is associated with activation of AMPK and mitigation of oxidative stress. Phytother Res 2011; 25: 588-596.
33. Srivastava S and Chan C. Hydrogen peroxide and hydroxyl radicals mediate palmitateinduced cytotoxicity to hepatoma cells: relation to mitochondrial permeability transition. Free Radic Res 2007; 41: 38-49.
34. Chou WC, Jie C, Kenedy AA, Jones RJ, Trush MA, and Dang CV. Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells. Proc Natl Acad Sci U S A 2004; 101: 4578-4583.
35. Wilson LA, Gemin A, Espiritu R, and Singh G. ets-1 is transcriptionally up-regulated by H2O2 via an antioxidant response element. FASEB J 2005; 19: 2085-2087.
36. Jiang Y, Xu W, Lu J, He F, and Yang X. Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, cmet, and transcription factor Ets-1. Biochem Biophys Res Commun 2001; 286: 1123-1130.
37. Kanda K, Nakayama T, Onizuka S, Tomioka T, and Kanematsu T. Expression of the Ets-1 proto-oncogene is linked to cell differentiation of human hepatocellular carcinoma. Hepatogastroenterology 2002; 49: 747-751.
38. Ozaki I, Mizuta T, Zhao G, Zhang H, Yoshimura T, Kawazoe S, Eguchi Y, Yasutake T, Hisatomi A, Sakai T, and Yamamoto K. Induction of multiple matrix metalloproteinase genes in human hepatocellular carcinoma by hepatocyte growth factor via a transcription factor Ets -1. Hepatol Res 2003; 27: 289-301.